Patterns of complementary and alternative medicine use among patients undergoing cancer treatment

被引:47
作者
Corner, J. [1 ]
Yardley, J. [1 ]
Maher, E. J. [2 ]
Roffe, L. [1 ]
Young, T. [2 ]
Maslin-Prothero, S. [3 ]
Gwilliam, C. [2 ]
Haviland, J. [4 ]
Lewith, G. [5 ]
机构
[1] Univ Southampton, Sch Nursing & Midwifery, Southampton SO17 1BJ, Hants, England
[2] Mt Vernon Canc Ctr, Lynda Jackson Macmillan Ctr, Support Oncol Res Team, Northwood, Middx, England
[3] Keele Univ, Sch Nursing & Midwifery, Stoke On Trent, Staffs, England
[4] Canc Res Inst, CTSU, Sutton, Surrey, England
[5] Univ Southampton, Sch Med, Complementary Med Res Unit, Aldermoor Hlth Ctr, Southampton SO17 1BJ, Hants, England
关键词
complementary medicine; alternative medicine; cancer; cancer treatment; PREVALENCE; THERAPIES;
D O I
10.1111/j.1365-2354.2007.00911.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to assess the prevalence of complementary and alternative medicine (CAM) use in a representative cancer population prior to and within 6 months of diagnosis. A total of 304 newly diagnosed cancer patients from two UK cancer centres completed a postal survey. Of them, 100 patients (32.9%) used CAM before their cancer diagnosis, 59 of these CAM users continued post diagnosis. Twenty-nine individuals who had not used CAM before began to use it after their cancer diagnosis, creating a total of 88 (28.9%) CAM users in this sample. Reasons for not using CAM included lack of interest, lack of information or endorsement from professionals and satisfaction with conventional care. For those using CAM before diagnosis but not afterwards, the most common reason was a lack of expert guidance on what was safe to use. The use of CAM medicines bought from health food and other retail outlets was high. Complementary and alternative medicine use in cancer patients is common and demonstrates a complex pattern, but CAM use is not significantly greater than in the general population. Some patients purchase CAM medicines without seeking medical advice, thus risking drug interactions. Research to generate information on safety and efficacy of CAM is required.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 20 条
  • [1] [Anonymous], 1988, HLTH DEPRIVATION INE
  • [2] *CANC UK, 2001, UK CANC INC STAT COU
  • [3] CONTEMPORARY UNORTHODOX TREATMENTS IN CANCER MEDICINE - A STUDY OF PATIENTS, TREATMENTS, AND PRACTITIONERS
    CASSILETH, BR
    LUSK, EJ
    STROUSE, TB
    BODENHEIMER, BJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (01) : 105 - 112
  • [4] PURSUIT AND PRACTICE OF COMPLEMENTARY THERAPIES BY CANCER-PATIENTS RECEIVING CONVENTIONAL TREATMENT
    DOWNER, SM
    CODY, MM
    MCCLUSKEY, P
    WILSON, PD
    ARNOTT, SJ
    LISTER, TA
    SLEVIN, ML
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6947) : 86 - 89
  • [5] UNCONVENTIONAL MEDICINE IN THE UNITED-STATES - PREVALENCE, COSTS, AND PATTERNS OF USE
    EISENBERG, DM
    KESSLER, RC
    FOSTER, C
    NORLOCK, FE
    CALKINS, DR
    DELBANCO, TL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) : 246 - 252
  • [6] Eng J L, 2001, Chronic Dis Can, V22, P102
  • [7] Ernst E, 1998, CANCER-AM CANCER SOC, V83, P777, DOI 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO
  • [8] 2-O
  • [9] MEDICINE IN EUROPE .8. COMPLEMENTARY MEDICINE IN EUROPE
    FISHER, P
    WARD, A
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6947) : 107 - 111
  • [10] Herb-drug interactions
    Fugh-Berman, A
    [J]. LANCET, 2000, 355 (9198) : 134 - 138